Healthcare IT Today November 7, 2025
Funding Fuels AI-Enabled Personalization, Commercial Expansion, and Partnerships With Leading Employers and Payors
WellTheory, the leading whole-person care platform for autoimmune disease, today announced it has raised $14 million in Series A funding led by General Catalyst with participation from new and existing investors, including 7wire Ventures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer, and Up2 Opportunity Fund. With $26.2 million in total capital, this new funding will fuel WellTheory’s commercial growth, accelerate AI development, and expand programs that meet growing demand from employers and payors.
Autoimmune disease is one of the fastest-growing and most expensive categories in healthcare, doubling over the last three decades and affecting more than 50 million Americans living with conditions such as rheumatoid arthritis,...
Today's Sponsors
Today's Sponsor